BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27395023)

  • 1. [Invasive yeast infections in neutropenic patients].
    Ruiz Camps I; Jarque I
    Rev Iberoam Micol; 2016; 33(3):170-5. PubMed ID: 27395023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current aspects of invasive diseases caused by Candida and other yeast fungi].
    Pemán J; Quindós G
    Rev Iberoam Micol; 2016; 33(3):133-9. PubMed ID: 27067876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study.
    Mariette C; Tavernier E; Hocquet D; Huynh A; Isnard F; Legrand F; Lhéritier V; Raffoux E; Dombret H; Ifrah N; Cahn JY; Thiébaut A
    Leuk Lymphoma; 2017 Mar; 58(3):586-593. PubMed ID: 27397551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invasive yeast diseases in solid organ transplant recipients].
    Muñoz P; Aguado JM
    Rev Iberoam Micol; 2016; 33(3):152-9. PubMed ID: 27142561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated fungal infection due to Saprochaete clavata in a kidney transplant recipient.
    Pavone P; Oliva A; Raponi G; Pugliese F; Martelli S; Celli P; Sacco F; Vullo V; Mastroianni CM; Russo G
    J Mycol Med; 2019 Sep; 29(3):278-281. PubMed ID: 31202517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update on invasive candidiasis in non-neutropenic critically ill adult patients].
    Zaragoza R; Ramírez P; Borges M; Pemán J
    Rev Iberoam Micol; 2016; 33(3):145-51. PubMed ID: 27395022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining standards of CARE for invasive fungal diseases in the ICU.
    Cuenca-Estrella M; Kett DH; Wauters J
    J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii9-ii15. PubMed ID: 31222308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients.
    Bays DJ; Thompson GR
    Infect Dis Clin North Am; 2019 Jun; 33(2):545-566. PubMed ID: 31005138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.
    Gamaletsou MN; Walsh TJ; Sipsas NV
    Turk J Haematol; 2018 Mar; 35(1):1-11. PubMed ID: 29391334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive Fungal Infections in the Intensive Care Unit.
    Ostrosky-Zeichner L; Al-Obaidi M
    Infect Dis Clin North Am; 2017 Sep; 31(3):475-487. PubMed ID: 28687215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
    Rimek D; Redetzke K; Kappe R
    Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of invasive fungal diseases in non-neutropenic ICU patients, with focus on candidiasis and aspergillosis: a comprehensive review.
    Azim A; Ahmed A
    Front Cell Infect Microbiol; 2024; 14():1256158. PubMed ID: 38505289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of invasive candidiasis in neutropenic patients: systematic review of randomized controlled treatment trials.
    Kanji JN; Laverdière M; Rotstein C; Walsh TJ; Shah PS; Haider S
    Leuk Lymphoma; 2013 Jul; 54(7):1479-87. PubMed ID: 23113686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.
    Arendrup MC; Boekhout T; Akova M; Meis JF; Cornely OA; Lortholary O; ;
    Clin Microbiol Infect; 2014 Apr; 20 Suppl 3():76-98. PubMed ID: 24102785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Invasive fungal infections in children: similarities and differences with adults].
    Ramos JT; Francisco L; Daoud Z
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():59-65. PubMed ID: 27608317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidemia and invasive candidiasis in adults: A narrative review.
    Antinori S; Milazzo L; Sollima S; Galli M; Corbellino M
    Eur J Intern Med; 2016 Oct; 34():21-28. PubMed ID: 27394927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
    Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
    Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive candidiasis in the neutropenic patient.
    Fortún J; Gioia F
    Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():22-25. PubMed ID: 28882010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis in neutropenic patients with hematologic malignancies: is there a real benefit?
    Böhme A; Karthaus M; Hoelzer D
    Chemotherapy; 1999; 45(3):224-32. PubMed ID: 10224346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.